TL;DR
Rooted Owl has appointed Dr. Barbara Royal, DVM, as senior veterinary advisor and head of nutrition. The company says she will advise on formulations, clinical studies and veterinary education, while its planned 12-product feline line is in final formulation.
Rooted Owl has named Dr. Barbara Royal, DVM, its senior veterinary advisor and head of nutrition, giving the natural pet health company a new adviser for product formulation and clinical research. The company also said a 12-product feline line is in final formulation and is scheduled to launch in the coming months.
In her new role, Royal will guide product formulation, clinical study design and education for veterinary professionals, according to the company. She is also expected to work on new formulations and engage with prospective retail and clinical partners. Rooted Owl described the appointment as part of its effort to apply clinical evidence and ingredient transparency to its products.
Royal is an owner and CEO of Animal Diet Formulator and the College of Integrative Veterinary Therapies. Rooted Owl says its existing portfolio includes 14 products and that it has completed clinical studies on core formulations, including its Hemp Calming Oil. The company reports that two additional clinical studies are underway, with topline data expected in 2026–2027.
The planned feline range is described as a complete 12-SKU line, with targeted products including Cardio Support and Kidney Support. Rooted Owl says its products are sold through its website and distributors including Amazon, Chewy, Petco Mexico and retail partners. The company did not provide specific launch dates or detailed study results in the announcement.
Royal’s Role in Product Development
The appointment places an experienced integrative veterinarian in a role that can influence how Rooted Owl formulates products and designs studies to evaluate them. For veterinary professionals and pet owners, the practical test will be whether the company makes study methods and findings available and how those findings inform product claims.
The feline line would extend the company’s range to additional cat health areas, including heart and kidney support. Those product categories concern health conditions that can require veterinary diagnosis and care; supplements should not be taken as a substitute for that care. The announcement describes the planned products but gives no formulation details or evidence specific to them.
As an affiliate, we earn on qualifying purchases.
Rooted Owl’s Research Plans
Rooted Owl is a brand developed by Animal & Plant Sciences LLC, which the announcement identifies as a New York-based company. It says its approach centers on formulations intended to be defensible in clinical settings and notes that it holds National Animal Supplement Council certification. The source does not independently document the company’s certification or research claims.
The company says it has completed multiple clinical studies on existing products and has two more in progress. It also describes its Joint & Muscle Health product, combining UC-II undenatured type II collagen and L-Carnitine, as the first commercialized combination of those ingredients in the U.S. pet supplement category. That is the company’s characterization; the announcement provides no supporting market comparison.
““Dr. Royal joining Rooted Owl is a defining moment for us.””
— Karan S. Madan, founder and CEO of Animal & Plant Sciences
As an affiliate, we earn on qualifying purchases.
Study Results and Launch Details
The announcement does not name the two ongoing studies, provide their protocols or identify the products being studied. It says topline data are expected in 2026–2027, but does not give publication plans or explain what the results will measure.
Rooted Owl has not provided a specific launch date for the feline range, ingredient lists, prices or evidence supporting the planned Cardio Support and Kidney Support products. The appointment announcement also does not detail Royal’s specific commitments or how her advice will be reflected in product decisions.
As an affiliate, we earn on qualifying purchases.
Feline Products and Study Updates
Rooted Owl says it plans to launch the 12-product feline line in the coming months. The company’s next updates may clarify timing, formulations and how the products are intended to be used alongside veterinary care.
Topline results from the two active studies are expected in 2026–2027, according to Rooted Owl. No dates for interim findings or other research milestones were announced.
veterinary formulated cat supplements
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What role will Dr. Barbara Royal have at Rooted Owl?
Rooted Owl named Royal senior veterinary advisor and head of nutrition. The company says she will advise on formulation, clinical study design and veterinary education, and help develop products.
What is Rooted Owl’s planned feline line?
The company says a 12-product feline line is in final formulation and scheduled to launch in the coming months. It named Cardio Support and Kidney Support as examples but did not release full product details.
When will Rooted Owl release clinical study results?
Rooted Owl says topline data from two ongoing studies are expected in 2026–2027. The announcement did not identify the studies or give specific release dates.
Does the announcement provide evidence for the new cat products?
No product-specific study results or formulation details for the planned feline line were included. The company described its research on existing formulations, but those claims do not establish evidence for the upcoming products.
Source: rss
